Mutual Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$277K Buy
1,415
+97
+7% +$18.8K 0.01% 1153
2025
Q4
$229K Buy
1,318
+18
+1% +$3.28K ﹤0.01% 1197
2025
Q3
$238K Sell
1,300
-46
-3% -$8.16K 0.01% 1152
2025
Q2
$227K Sell
1,346
-1,265
-48% -$220K 0.01% 1087
2025
Q1
$454K Buy
2,611
+1,151
+79% +$189K 0.01% 756
2024
Q4
$221K Buy
+1,460
New +$227K 0.01% 988
2024
Q2
Sell
-2,145
Closed -$286K 1099
2024
Q1
$286K Buy
+2,145
New +$278K 0.01% 887
2023
Q4
Sell
-1,656
Closed -$202K 1025
2023
Q3
$202K Sell
1,656
-2,455
-60% -$327K 0.01% 921
2023
Q2
$578K Buy
4,111
+2,500
+155% +$345K 0.02% 594
2023
Q1
$228K Sell
1,611
-15
-0.9% -$2.15K 0.01% 874
2022
Q4
$254K Sell
1,626
-77
-5% -$11.1K 0.01% 791
2022
Q3
$209K Buy
1,703
+32
+2% +$4.21K 0.01% 820
2022
Q2
$222K Buy
1,671
+1
+0.1% +$136 0.01% 762
2022
Q1
$229K Sell
1,670
-7
-0.4% -$976 0.01% 788
2021
Q4
$290K Buy
1,677
+8
+0.5% +$1.22K 0.02% 751
2021
Q3
$243K Sell
1,669
-118
-7% -$17.3K 0.01% 772
2021
Q2
$236K Buy
1,787
+183
+11% +$24K 0.01% 748
2021
Q1
$206K Buy
+1,604
New +$198K 0.01% 727

Other funds holding DGX

Mutual Advisors's DGX Position: Q1 2026 in Review

Mutual Advisors increased its Quest Diagnostics (DGX) stake by 7.4% in Q1 2026, buying an estimated $18.8K and bringing the position to 1,415 shares worth $277K. The position accounts for 0.01% of the portfolio, ranked #1153.

Mutual Advisors first reported a position in DGX in Q1 2021 and has held it in 18 quarters since. The position peaked at $578K in Q2 2023. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Mutual Advisors held 1,415 shares of Quest Diagnostics worth $277K as of Q1 2026.
  • Mutual Advisors bought 97 Quest Diagnostics shares in Q1 2026, an estimated $18.8K.
  • Quest Diagnostics made up 0.01% of Mutual Advisors's portfolio in Q1 2026, its #1153 holding.
  • Mutual Advisors first reported a position in Quest Diagnostics in Q1 2021 and has held it in 18 quarters since.
  • Mutual Advisors's Quest Diagnostics position peaked at $578K in Q2 2023.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.